THE 3' HALF OF THE MOUSE MAMMARY-TUMOR VIRUS ORF GENE IS NOT SUFFICIENT FOR ITS SUPERANTIGEN FUNCTION IN TRANSGENIC MICE

Citation
Jf. Lambert et al., THE 3' HALF OF THE MOUSE MAMMARY-TUMOR VIRUS ORF GENE IS NOT SUFFICIENT FOR ITS SUPERANTIGEN FUNCTION IN TRANSGENIC MICE, Molecular immunology, 30(16), 1993, pp. 1399-1404
Citations number
29
Categorie Soggetti
Immunology,Biology
Journal title
ISSN journal
01615890
Volume
30
Issue
16
Year of publication
1993
Pages
1399 - 1404
Database
ISI
SICI code
0161-5890(1993)30:16<1399:T3HOTM>2.0.ZU;2-X
Abstract
The Mouse Mammary Tumor Virus (MMTV) long terminal repeat contains an open reading frame (orf) of 960 nucleotides encoding a 36 kDa polypept ide with a putative transmembrane domain and five N-glycosylation site s in the N-terminal part of the protein. Transgenic mice bearing eithe r the complete or the 3' terminal half of the orf sequence of MMTV-GR under the control of the SV40 promoter were raised. As shown previousl y by FACS analysis transgenic mice which express the complete orf gene have a significant deletion of Vbeta14 expressing T cells at 6 weeks of age. Here we show that no clonal deletion of Vbeta14 bearing T cell s takes place in transgenic mice that contain orf sequences from the f ifth ATG to the termination codon. The pattern of tissues expressing t he truncated transgene was studied by the Polymerase Chain Reaction (P CR) and was very similar to the one obtained in the Vbeta14 deleting a nimals. These data suggest that the amino-terminal portion of the ORF protein (pORF) is required for a superantigen function, while our prev ious data indicated that determinants from the carboxy-terminus play a n important role for TCR Vbeta specificity.